2nd Quarter - Report

VAN HEUVELEN STRATEGIES, LLC for GENERIC PHARMACEUTICAL ASSOCIATION

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R. 325- Continuing Resolution; S. Con. Res. 8, FY 2014 Budget Resolution

LobbyistCovered position, as disclosed
DIANE MAJOR Legislative Assistant, Congressman Craig Thomas
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 8 (113th), H.R. 325 (113th)

Health Issues HCR

Prescription drug user fee act and other issues related to generic drugs; H.R. 1919 Safeguarding America's Pharmaceuticals Act of 2013; S. 959 Pharmaceutical Compounding Quality and Accountability Act; S. 2295 Patient Safety and Generic Labeling Improvement Act.

LobbyistCovered position, as disclosed
DIANE MAJOR Legislative Assistant, Congressman Craig Thomas
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 959 (113th), S. 2295 (113th), H.R. 1919 (113th)

Labor Issues/Antitrust/Workplace LBR

Issues related to patent settlements; S. 214 Preserve Access to Affordable Generics Act

LobbyistCovered position, as disclosed
DIANE MAJOR Legislative Assistant, Congressman Craig Thomas
ROBERT VAN HEUVELEN Chief of Staff to Senator Kent Conrad

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 214 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.